{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:49Z","timestamp":1793126029819,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["TKP2021-EGA-32"],"award-info":[{"award-number":["TKP2021-EGA-32"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107674","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:18:24Z","timestamp":1790291904000},"page":"107674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated experimental\u2013computational platform for evaluating blood\u2013brain barrier permeability of novel kynurenic acid derivatives"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3299-0884","authenticated-orcid":false,"given":"Zahraa","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-0034","authenticated-orcid":false,"given":"B\u00e1lint","family":"L\u0151rinczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Fazakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imola","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0611-1452","authenticated-orcid":false,"given":"Ferenc","family":"Bog\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8207-2522","authenticated-orcid":false,"given":"Linda","family":"Szilasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Ilisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9076-2177","authenticated-orcid":false,"given":"R\u00f3bert","family":"Berkecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107674_bib1","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.chroma.2010.01.071","article-title":"A high throughput dried DMSO LogD lipophilicity measurement based on 96-well shake-flask and atmospheric pressure photoionization mass spectrometry detection","volume":"1217","author":"Alelyunas","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejps.2026.107674_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25169082","article-title":"The biology and biochemistry of kynurenic acid, a potential nutraceutical with multiple biological effects","volume":"25","author":"Alves","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/elps.201700400","article-title":"LC-HRMS\/MS method for simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma","volume":"39","author":"Arnhard","year":"2018","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejps.2026.107674_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejps.2026.107674_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702764","article-title":"Kynurenic acid and its analogue SZR-72 ameliorate the severity of experimental acute necrotizing pancreatitis","volume":"12","author":"Balla","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107674_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2025.138220","article-title":"Age-dependent changes in NMDA-induced excitotoxicity and neuromodulatory effects of kynurenic acid and its analogue in mouse brain slices","volume":"854","author":"Balog","year":"2025","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2026.107674_bib7","first-page":"54","volume":"68","author":"Balog","year":"2024","journal-title":"Acta Biol. Szeged."},{"key":"10.1016\/j.ejps.2026.107674_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0223-5234(96)80368-0","article-title":"Chromatographic indices determined on an immobilized artificial membrane (IAM) column as descriptors of lipophilic and polar interactions of 4-phenyldihydropyridine calcium-channel blockers with biomembranes","volume":"31","author":"Barbato","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2026.107674_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14050589","article-title":"Physicochemical characterization of kynurenine pathway metabolites","volume":"14","author":"Buz\u00e1sy","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejps.2026.107674_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020583","article-title":"The Kynurenine pathway in Attention-Deficit\/Hyperactivity disorder: a systematic review and meta-analysis of blood concentrations of tryptophan and its catabolites","volume":"13","author":"Cavaleri","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejps.2026.107674_bib12","unstructured":"ChemAxon, Calculator plugins: logD plugin (web-based prediction tool). https:\/\/docs.chemaxon.com\/display\/docs\/calculators_logd-plugin.md, 2024 (accessed 1 February 2024)."},{"key":"10.1016\/j.ejps.2026.107674_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-011-0755-x","article-title":"A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures: an electrophysiological study","volume":"119","author":"Demeter","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejps.2026.107674_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914522","article-title":"Differential effects of hypothermia and SZR72 on cerebral kynurenine and kynurenic acid in a piglet model of hypoxic-ischemic encephalopathy","volume":"24","author":"Domoki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2018.05.032","article-title":"Simultaneous determination of tryptophan, kynurenine, kynurenic acid and two monoamines in rat plasma by HPLC-ECD\/DAD","volume":"158","author":"Du","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2026.107674_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/ci0102721","article-title":"Prediction of CNS activity of compound libraries using substructure analysis","volume":"43","author":"Engkvist","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib17","article-title":"Dynamic changes in metabolites of the kynurenine pathway in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a systematic review and meta-analysis","volume":"13","author":"Fathi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107674_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24193502","article-title":"Structural evaluation and electrophysiological effects of some kynurenic acid analogs","volume":"24","author":"Feh\u00e9r","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107674_bib19","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1080\/01483919108049396","article-title":"A rapid microscale method for the determination of partition coefficients by HPLC","volume":"14","author":"Ford","year":"1991","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.ejps.2026.107674_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2006.09.019","article-title":"Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids","volume":"377","author":"Fukushima","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2026.107674_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/bmc.786","article-title":"Determination of rat brain kynurenic acid by column-switching HPLC with fluorescence detection","volume":"21","author":"Fukushima","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2026.107674_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768560","article-title":"Kynurenine pathway metabolites as potential clinical biomarkers in coronary artery disease","volume":"12","author":"G\u00e1sp\u00e1r","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107674_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136933","article-title":"Kynurenic acid\/AhR signaling at the junction of inflammation and cardiovascular diseases","volume":"25","author":"Grishanova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2010.05.016","article-title":"Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity","volume":"15","author":"Hill","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2026.107674_bib25","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH guideline M10: bioanalytical method validation and study sample analysis (step 4). https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf 2022 (accessed 12 February 2026)."},{"key":"10.1016\/j.ejps.2026.107674_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s41664-017-0026-4","article-title":"MS-based metabolomics for the investigation of neuro-metabolic changes associated with BDE-47 exposure in C57BL\/6 mice","volume":"1","author":"Ji","year":"2017","journal-title":"J. Anal. Test."},{"key":"10.1016\/j.ejps.2026.107674_bib27","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pKa and protonation state prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejps.2026.107674_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.566582","article-title":"Divergent effects of the N-methyl-d-aspartate receptor antagonist kynurenic acid and the synthetic analog SZR-72 on microcirculatory and mitochondrial dysfunction in experimental sepsis","volume":"7","author":"Juh\u00e1sz","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejps.2026.107674_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neures.2008.04.009","article-title":"The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid","volume":"61","author":"Knyih\u00e1r-Csillik","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejps.2026.107674_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094822","article-title":"The kynurenic acid analog SZR72 enhances neuronal activity after asphyxia but is not neuroprotective in a translational model of neonatal hypoxic ischemic encephalopathy","volume":"22","author":"Kov\u00e1cs","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107674_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040937","article-title":"Synthesis of new C-3 substituted kynurenic acid derivatives","volume":"25","author":"L\u0151rinczi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2026.107674_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2016.06.024","article-title":"Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format","volume":"92","author":"Low","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cells14130973","article-title":"Tanaka, decoupling behavioral domains via Kynurenic Acid analog optimization: implications for schizophrenia and Parkinson's disease therapeutics","volume":"14","author":"Martos","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107674_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010061","article-title":"SZR-104, a novel kynurenic acid analogue with high permeability through the blood\u2013brain barrier","volume":"13","author":"Moln\u00e1r","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107674_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2022.07.009","article-title":"Validation of an LC-MS\/MS method for simultaneous quantification of tryptophan and 10 key kynurenine pathway metabolites in plasma and urine: application to acute kidney injury","volume":"534","author":"Nadour","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2026.107674_bib37","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.neuropharm.2004.06.007","article-title":"Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study","volume":"47","author":"N\u00e9meth","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2026.107674_bib38","doi-asserted-by":"crossref","first-page":"30626","DOI":"10.1021\/jacs.5c02578","article-title":"Solvation free energies of anions: from curated reference data to predictive models","volume":"147","author":"Nevolianis","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2026.107674_bib39","series-title":"OECD Guidelines for the Testing of Chemicals, Section 1","article-title":"Test No. 107: partition coefficient (n-octanol\/water): shake flask method","year":"1995"},{"key":"10.1016\/j.ejps.2026.107674_bib40","series-title":"OECD Guidelines for the Testing of Chemicals, Section 1","article-title":"Test No. 117: partition coefficient (n-octanol\/water), HPLC method","year":"2022"},{"key":"10.1016\/j.ejps.2026.107674_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39774-3","article-title":"LC-MS\/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples","volume":"13","author":"Pedraz-Petrozzi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107674_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122700","article-title":"Selective and sensitive UHPLC-ESI-Orbitrap MS method to quantify protein oxidation markers","volume":"234","author":"Poojary","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.ejps.2026.107674_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120574","article-title":"Simultaneous voltammetric analysis of tryptophan and kynurenine in culture medium from human cancer cells","volume":"209","author":"Sadok","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.ejps.2026.107674_bib44","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1039\/D4RA04341C","article-title":"Ortho-quinone methide driven synthesis of kynurenic acid lactams","volume":"14","author":"S\u00e1rik","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2026.107674_bib45","series-title":"Schr\u00f6dinger Release 2025-3 [Software]","year":"2025"},{"key":"10.1016\/j.ejps.2026.107674_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138077","article-title":"Structural analysis of kynurenic acid and derivatives by NMR spectroscopy and DFT calculations","volume":"1308","author":"Shmidt","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2026.107674_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2019.107516","article-title":"A classification model for blood brain barrier penetration","volume":"96","author":"Singh","year":"2020","journal-title":"J. Mol. Graph. Model"},{"key":"10.1016\/j.ejps.2026.107674_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113997","article-title":"Development and validation of an LC method using UV\/fluorescence detection for quantitative determination of kynurenine pathway metabolites in human urine: application to heart failure","volume":"198","author":"Sousa","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.ejps.2026.107674_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae416","article-title":"ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries","volume":"40","author":"Swanson","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2026.107674_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4156","article-title":"Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and serotonin in human plasma by LC-MS\/MS and its application to acute myocardial infarction monitoring","volume":"32","author":"Tong","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2026.107674_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2026.107674_bib52","article-title":"Efficient and accurate pKa prediction enabled by pre-trained machine-learned interatomic potentials","author":"Wagen","year":"2024","journal-title":"ChemRxiv [preprint]"},{"key":"10.1016\/j.ejps.2026.107674_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-019-03332-w","article-title":"Kynurenic acid and cancer: facts and controversies","volume":"77","author":"Walczak","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib54","series-title":"BBB Permeability (GEB): logBB prediction","year":"2024"},{"key":"10.1016\/j.ejps.2026.107674_bib55","series-title":"ACS Organic Division","article-title":"pKa Data Compiled by R. Williams","author":"Williams","year":"2022"},{"key":"10.1016\/j.ejps.2026.107674_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/1386207013330913","article-title":"High throughput log D determination using liquid chromatography-mass spectrometry","volume":"4","author":"Wilson","year":"2001","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.ejps.2026.107674_bib57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1039\/c2pp25357g","article-title":"Photochemistry of aqueous solutions of kynurenic acid and kynurenine yellow","volume":"12","author":"Zelentsova","year":"2013","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.ejps.2026.107674_bib58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jchromb.2010.01.006","article-title":"Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by HPLC","volume":"878","author":"Zhao","year":"2010","journal-title":"J. Chromatogr. B"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:52:43Z","timestamp":1793123563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S0928098726002484"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107674","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated experimental\u2013computational platform for evaluating blood\u2013brain barrier permeability of novel kynurenic acid derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107674"}}